Novavax signs manufacturing deal with Endo for potential Covid-19 vaccine

Novavax Inc has signed an agreement with Endo International for manufacturing its experimental Covid-19 vaccine, the generic drugmaker said on Friday.

Endo said its unit Par Sterile has begun production of the final drug product, with initial batches to be used in Novavax's phase-3 clinical trial in the United States.